Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients’ care

References

• Mavrogeni SI, Kitas GD, Dimitroulas T, et al. Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol. 2016;217:135–148. doi:10.1016/j.ijcard.2016.04.158.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, D’Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295–301. doi:10.1161/CIRCIMAGING.112.000151.
   PubMed Web of Science ®Google Scholar
• Ntusi NA, Piechnik SK, Francis JM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson. 2014;16(1):21. doi:10.1186/1532-429X-16-21.
   PubMed Web of Science ®Google Scholar
• Marchant DJ, Boyd JH, Lin DC, et al. Inflammation in myocardial diseases. Circ Res. 2012;110(1):126–144. doi:10.1161/CIRCRESAHA.111.243170.
   PubMed Web of Science ®Google Scholar
• Barison A, Gargani L, De Marchi D, et al. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015;16(1):74–80. doi:10.1093/ehjci/jeu167.
   PubMed Web of Science ®Google Scholar
• Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC: Cardiovascular Imaging. 2013;6(4):501–511. doi:10.1016/j.jcmg.2012.10.021.
   PubMed Web of Science ®Google Scholar
• Isted A, Grigoratos C, Bratis K, et al. Native T1 in deciphering the reversible myocardial inflammation in cardiac sarcoidosis with anti-inflammatory treatment. Int J Cardiol. 2016;203:459–462. doi:10.1016/j.ijcard.2015.10.199.
   PubMed Web of Science ®Google Scholar
• Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J. 2007;28(15):1797–1804. doi:10.1093/eurheartj/ehm193.
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636–2648. doi:10.1093/eurheartj/eht210.
   PubMed Web of Science ®Google Scholar
• Arbustini E, Narula N, Dec GW, et al. The MOGE(S) classification for a phenotype–genotype nomenclature of cardiomyopathy. J Am Coll Cardiol. 2013;62(22):2046–2072. doi:10.1016/j.jacc.2013.08.1644.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Carr-White G, Jabbour A, et al. T1-mapping and outcome in nonischemic cardiomyopathy. JACC: Cardiovascular Imaging. 2016;9(1):40–50. doi:10.1016/j.jcmg.2015.12.001.
   PubMed Web of Science ®Google Scholar
• Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969–1977. doi:10.1161/CIRCULATIONAHA.109.851352.
   PubMed Web of Science ®Google Scholar
• Symmons DPM, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7(7):399–408. doi:10.1038/nrrheum.2011.75.
   PubMed Web of Science ®Google Scholar
• Valbuena-López S, Hinojar R, Puntmann VO. Cardiovascular magnetic resonance in cardiology practice: a concise guide to image acquisition and clinical interpretation. Revista Española De Cardiología (English Edition). 2016;69(2):202–210. doi:10.1016/j.rec.2015.11.011.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Botnar R, Kaski JC, et al. Individualized cardiovascular risk assessment by cardiovascular magnetic resonance. Future Cardiol. 2014;10(2):273–289. doi:10.2217/fca.13.102.
   PubMedGoogle Scholar
• Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J. 2007;28(10):1242–1249. doi:10.1093/eurheartj/ehm113.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Foote L, Cummins C, et al. Standardised postprocessing of native T2 in detection and discrimination of myocarditis - comparison with native T1 mapping. J Cardiovasc Magn Reson. 2016;18(Suppl1):O14. doi:10.1186/1532-429X-18-S1-O14.
   Google Scholar
• Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37(3):267–315. doi:10.1093/eurheartj/ehv320.
   PubMed Web of Science ®Google Scholar
• Grothues F, Smith GC, Moon JCC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34. doi:10.1016/S0002-9149(02)02381-0.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Gebker R, Duckett S, et al. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. Eur Heart J Cardiovasc Imaging. 2013;14(3):240–246. doi:10.1093/ehjci/jes145.
   PubMed Web of Science ®Google Scholar
• Schulz-Menger J. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2005;92(3):399–400. doi:10.1136/hrt.2004.058016.
   Web of Science ®Google Scholar
• Mavrogeni S, Sfikakis PP, Gialafos E, et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res. 2013;66(1):104–112. doi:10.1002/acr.22181.
   Web of Science ®Google Scholar
• Taylor AJ, Salerno M, Dharmakumar R, et al. T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging. 2016 Jan;9(1):67–81. doi:10.1016/j.jcmg.2015.11.005.
   Google Scholar
• Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183(5):573–581. doi:10.1164/rccm.201006-0865CI.
   PubMed Web of Science ®Google Scholar
• Nicola PJ, Maradit-Kremers H, Roger VRL, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005;52(2):412–420. doi:10.1002/art.20855.
   PubMed Web of Science ®Google Scholar
• Authors/Task Force members, McMurray JJV, Adamopoulos S, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail. 2014;14(8):803–869. doi:10.1093/eurjhf/hfs105.
   Web of Science ®Google Scholar
• Authors/Task Force members, Perk J, De Backer G, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) • developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J. 2012;33(13):1635–1701. doi:10.1093/eurheartj/ehs092.
   PubMed Web of Science ®Google Scholar
• McTiernan CF, Feldman AM. The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure. Curr Cardiol Rep. 2000;2(3):189–197. doi:10.1007/s11886-000-0068-4.
   PubMedGoogle Scholar
• Hurlimann D. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106(17):2184–2187. doi:10.1161/01.CIR.0000037521.71373.44.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, D’Cruz D, Taylor PC, et al. Contrast enhancement imaging in coronary arteries in sle. JACC: Cardiovascular Imaging. 2012;5(9):962–964. doi:10.1016/j.jcmg.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Varma N, Hinojar R, D’Cruz D, et al. Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement. JACC: Cardiovascular Imaging. 2014;7(8):762–770. doi:10.1016/j.jcmg.2014.03.012.
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Ohman ML, Nived O, et al. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study. Lupus. 2012;21(4):452–459. doi:10.1177/0961203311425524.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Bigalke B, Nagel E. Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventions. Trends Cardiovasc Med. 2010;20(5):176–181. doi:10.1016/j.tcm.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Van Leuven SI, Franssen R, Kastelein JJ, et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology. 2008;47(1):3–7. doi:10.1093/rheumatology/kem202.
   PubMed Web of Science ®Google Scholar
• Pasceri V, Yeh ETH. A tale of two diseases : atherosclerosis and rheumatoid arthritis. Circulation. 1999;100(21):2124–2126. doi:10.1161/01.CIR.100.21.2124.
   PubMed Web of Science ®Google Scholar
• Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98(11):835–840. doi:10.1136/heartjnl-2012-301686.
   PubMed Web of Science ®Google Scholar
• Cruz-Adalia A, Jimenez-Borreguero LJ, Ramirez-Huesca M, et al. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation. 2010;122(14):1396–1404. doi:10.1161/CIRCULATIONAHA.110.952820.
   PubMed Web of Science ®Google Scholar
• Palmieri V, Migliaresi P, Orefice M, et al. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index. Nutrition, Metabolism Cardiovasc Dis. 2009;19(4):234–240. doi:10.1016/j.numecd.2008.09.009.
   PubMed Web of Science ®Google Scholar
• Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002;113(5):419–423. doi:10.1016/S0002-9343(02)01223-8.
   PubMed Web of Science ®Google Scholar
• Lewis MJ, Malik TH, Fossati-Jimack L, et al. Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia. Arthritis Rheum. 2012;64(8):2707–2718. doi:10.1002/art.34451.
   PubMed Web of Science ®Google Scholar
• Hamdulay SS, Wang B, Calay D, et al. Synergistic therapeutic vascular cytoprotection against complement-mediated injury induced via a PKC -, AMPK-, and CREB-Dependent Pathway. J Immunol. 2014;192(9):4316–4327. doi:10.4049/jimmunol.1301702.
   PubMed Web of Science ®Google Scholar
• Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol. 2012;24(4):401–407. doi:10.1097/BOR.0b013e328353372d.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Varma N, Child N, et al. T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathyCLINICAL PERSPECTIVE. Circ Cardiovasc Imaging. 2015;8(12):e003285. doi:10.1161/CIRCIMAGING.115.003285.
   Google Scholar
• Hill JA, Olson EN. Cardiac plasticity. New England J Med. 2008;358(13):1370–1380. doi:10.1056/NEJMra072139.
   PubMed Web of Science ®Google Scholar
• Weber KT, Sun Y, Bhattacharya SK, et al. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2012;10(1):15–26. doi:10.1038/nrcardio.2012.158.
   PubMed Web of Science ®Google Scholar
• Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779–792. doi:10.1016/j.jacc.2011.09.074.
   PubMed Web of Science ®Google Scholar
• Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC: Cardiovascular Imaging. 2012;5(5):513–524. doi:10.1016/j.jcmg.2011.11.022.
   PubMed Web of Science ®Google Scholar
• Baldeviano GC, Barin JG, Talor MV, et al. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res. 2010;106(10):1646–1655. doi:10.1161/CIRCRESAHA.109.213157.
   PubMed Web of Science ®Google Scholar
• Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15(1):91. doi:10.1186/1532-429X-15-91.
   PubMed Web of Science ®Google Scholar
• Ishimori ML, Agarwal M, Ng RK, et al. Lupus cardiomyopathy: a reversible form of left ventricular dysfunction. Arthritis Res Ther. 2012;14(Suppl3):A61. doi:10.1186/ar3995.
   Google Scholar
• Tonino PAL, De Bruyne B, Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New England J Med. 2009;360(3):213–224. doi:10.1056/NEJMoa0807611.
   PubMed Web of Science ®Google Scholar
• Hussain ST, Paul M, Plein S, et al. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson. 2012;14(1):65. doi:10.1186/1532-429X-14-65.
   PubMed Web of Science ®Google Scholar
• Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J. 2009;30(15):1837–1843. doi:10.1093/eurheartj/ehp205.
   PubMed Web of Science ®Google Scholar
• Ntusi NA, Piechnik SK, Francis JM, et al. Diffuse myocardial fibrosis is associated with impaired myocardial strain and disease activity in rheumatoid arthritis: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16(Suppl1):P292. doi:10.1186/1532-429X-16-S1-P292.
   Google Scholar
• Puntmann VO, Taylor PC, Barr A, et al. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology. 2010;49(3):528–535. doi:10.1093/rheumatology/kep426.
   PubMed Web of Science ®Google Scholar
• Claus P, Omar AMS, Pedrizzetti G, et al. Tissue tracking technology for assessing cardiac mechanics. JACC: Cardiovascular Imaging. 2015;8(12):1444–1460. doi:10.1016/j.jcmg.2015.11.001.
   PubMed Web of Science ®Google Scholar
• Cioffi G, Viapiana O, Ognibeni F, et al. Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with rheumatoid arthritis without overt cardiac disease. J Am Soc Echocardiography. 2016;29(7):689–698. doi:10.1016/j.echo.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Arroyo Ucar E, Hinojar Baydes R, et al. Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy. Hypertension. 2014;64(4):762–768. doi:10.1161/HYPERTENSIONAHA.114.03928.
   PubMed Web of Science ®Google Scholar
• Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Jama. 2013;309(9):896. doi:10.1001/jama.2013.1363.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Campbell MJ, et al. Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2014;7(1):100–106. doi:10.1161/CIRCIMAGING.113.000338.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Swift AJ, Capener D, et al. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol. 2012;39(6):1265–1274. doi:10.3899/jrheum.110987.
   PubMed Web of Science ®Google Scholar
• O’Neill SG, Woldman S, Bailliard F, et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis. 2009;68(9):1478–1481. doi:10.1136/ard.2008.098053.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Condliffe R, et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson. 2012;14(1):40. doi:10.1186/1532-429X-14-40.
   PubMed Web of Science ®Google Scholar
• Swift AJ, Rajaram S, Capener D, et al. LGE patterns in pulmonary hypertension do not impact overall mortality. JACC: Cardiovascular Imaging. 2014;7(12):1209–1217. doi:10.1016/j.jcmg.2014.08.014.
   PubMed Web of Science ®Google Scholar
• Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16(1):34. doi:10.1186/s12968-014-0069-x.
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52(2):402–411. doi:10.1002/art.20853.
   PubMed Web of Science ®Google Scholar
• Douglas KMJ. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis. 2006;65(3):348–353. doi:10.1136/ard.2005.037978.
   PubMed Web of Science ®Google Scholar
• Ntusi NAB, Piechnik SK, Francis JM, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis. JACC: Cardiovascular Imaging. 2015;8(5):526–536. doi:10.1016/j.jcmg.2014.12.025.
   PubMed Web of Science ®Google Scholar
• Di Cesare E, Battisti S, Di Sibio A, et al. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol. 2013;82(6):e268–e273. doi:10.1016/j.ejrad.2013.02.014.
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Gladman DD, Tom BDM, et al. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008;35(11):2152. doi:10.3899/jrheum.080214.
   PubMed Web of Science ®Google Scholar
• Van Leuven SI, Van Wijk DF, Volger OL, et al. Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis. Atherosclerosis. 2010;211(1):231–236. doi:10.1016/j.atherosclerosis.2010.01.043.
   PubMed Web of Science ®Google Scholar
• An J, Cheetham TC, Reynolds K, et al. Traditional cardiovascular disease risk factor management in rheumatoid arthritis compared to matched nonrheumatoid arthritis in a US managed care setting. Arthritis Care Res. 2016;68(5):629–637. doi:10.1002/acr.22740.
   Web of Science ®Google Scholar
• Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. New England J Med. 1997;337(23):1648–1653. doi:10.1056/NEJM199712043372302.
   PubMed Web of Science ®Google Scholar
• Puntmann VO. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J. 2009;85(1008):538–545. doi:10.1136/pgmj.2008.073759.
   PubMed Web of Science ®Google Scholar
• Costello BT, Iles LM, Stub D, et al. Biomarker validation of cardiac magnetic resonance analysis of regional myocardial fibrosis in ischaemic heart disease. J Cardiovasc Magn Reson. 2016;18(Suppl1):P77. doi:10.1186/1532-429X-18-S1-P77.
   Google Scholar
• Goykhman P, Mehta PK, Minissian M, et al. Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging. J Rheumatol. 2012;39(2):448–450. doi:10.3899/jrheum.110812.
   PubMed Web of Science ®Google Scholar
• Abdel-Aty H, Siegle N, Natusch A, et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus. 2008;17(6):561–567. doi:10.1177/0961203308089401.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Bratis K, Markussis V, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus. 2012;22(1):34–43. doi:10.1177/0961203312462265.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, Rossig L, Breuer S, et al. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation. 2001;104(25):3023–3025. doi:10.1161/hc5001.101749.
   PubMed Web of Science ®Google Scholar
• Karp G, Wolak A, Baumfeld Y, et al. Assessment of aortic stiffness among patients with systemic lupus erythematosus and rheumatoid arthritis by magnetic resonance imaging. Int J Cardiovasc Imaging. 2016;32(6):935–944. doi:10.1007/s10554-016-0851-y.
   PubMed Web of Science ®Google Scholar
• Maki-Petaja KM. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor- therapy. Circulation. 2006;114(11):1185–1192. doi:10.1161/CIRCULATIONAHA.105.601641.
   PubMed Web of Science ®Google Scholar
• Mattace-Raso F, Hofman A, Verwoert GC, et al. Reference values for arterial stiffness’ collaboration determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values”. Eur Heart J. 2010;31(19):2338–2350. doi:10.1093/eurheartj/ehq165
   PubMed Web of Science ®Google Scholar
• Mäki-Petäjä KM, Day L, Cheriyan J, et al. Tetrahydrobiopterin supplementation improves endothelial function but does not alter aortic stiffness in patients with rheumatoid arthritis. J Am Heart Assoc. 2016;5(2):e002762. doi:10.1161/JAHA.115.002762.
   Google Scholar
• Wong M, Oakley SP, Young L, et al. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68(8):1277–1284. doi:10.1136/ard.2007.086157.
   PubMed Web of Science ®Google Scholar
• Mathieu S, Pereira B, Dubost JJ, et al. No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment. Rheumatology. 2012;51(6):1107–1111. doi:10.1093/rheumatology/kes006.
   PubMed Web of Science ®Google Scholar
• Nagel E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108(4):432–437. doi:10.1161/01.CIR.0000080915.35024.A9.
   PubMed Web of Science ®Google Scholar
• Schwitter J, Wacker CM, Van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29(4):480–489. doi:10.1093/eurheartj/ehm617.
   PubMed Web of Science ®Google Scholar
• Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34(10):775–781. doi:10.1093/eurheartj/ehs022.
   PubMed Web of Science ®Google Scholar
• Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379(9814):453–460. doi:10.1016/S0140-6736(11)61335-4.
   PubMed Web of Science ®Google Scholar
• Jaarsma C, Leiner T, Bekkers S, et al. Diagnostic performance of PET, SPECT and CMR perfusion imaging for the detection of significant coronary artery disease - a meta-analysis. J Cardiovasc Magn Reson. 2011;13(Suppl1):P75. doi:10.1186/1532-429X-13-S1-P75.
   Google Scholar
• Kelle S, Roes SD, Klein C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol. 2009;54(19):1770–1777. doi:10.1016/j.jacc.2009.07.027.
   PubMed Web of Science ®Google Scholar
• Nagel E, Shaw LJ. The assessment of ischaemic burden: thoughts on definition and quantification. Eur Heart J Cardiovasc Imaging. 2014;15(6):610–611. doi:10.1093/ehjci/jeu029.
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Berman DS, Picard MH, et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC: Cardiovascular Imaging. 2014;7(6):593–604. doi:10.1016/j.jcmg.2013.10.021.
   PubMed Web of Science ®Google Scholar
• Greenwood JP, Motwani M, Maredia N, et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the clinical evaluation of magnetic resonance imaging in coronary heart disease (CE-MARC) trial. Circulation. 2014;129(10):1129–1138. doi:10.1161/CIRCULATIONAHA.112.000071.
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Olson MB, Kip K, et al. The value of estimated functional capacity in estimating outcome: results from the NHBLI-sponsored women’s ischemia syndrome evaluation (WISE) study. J Am Coll Cardiol. 2006;47(3Suppl):S36–S43. doi:10.1016/j.jacc.2005.03.080.
   Google Scholar
• Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3Suppl):S21–S29. doi:10.1016/j.jacc.2004.12.084.
   Google Scholar
• Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013:2949–3003. doi:10.1093/eurheartj/eht296
   PubMed Web of Science ®Google Scholar
• Ishimori ML, Martin R, Berman DS, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC: Cardiovascular Imaging. 2011;4(1):27–33. doi:10.1016/j.jcmg.2010.09.019.
   PubMed Web of Science ®Google Scholar
• Ishimori ML, Anderson L, Weisman MH, et al. Microvascular angina: an underappreciated cause of SLE chest pain. J Rheumatol. 2013;40(5):746–747. doi:10.3899/jrheum.121277.
   PubMed Web of Science ®Google Scholar
• Faccini A, Kaski JC, Camici PG. Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. Eur Heart J. 2016;37(23):1799–1806. doi:10.1093/eurheartj/ehw018.
   PubMed Web of Science ®Google Scholar
• Arroyo-Espliguero R. Microvascular dysfunction in cardiac syndrome X: the role of inflammation. Can Med Assoc J. 2006;174(13):1833–3. doi:10.1503/cmaj.051331.
   Web of Science ®Google Scholar
• Mehta PK, Goykhman P, Thomson LEJ, et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC: Cardiovascular Imaging. 2011;4(5):514–522. doi:10.1016/j.jcmg.2011.03.007.
   PubMed Web of Science ®Google Scholar
• White JA, Patel MR. The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin. 2007;25(1):71–95. doi:10.1016/j.ccl.2007.02.003.
   PubMed Web of Science ®Google Scholar
• Mewton N, Liu C-Y, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57(8):891–903. doi:10.1016/j.jacc.2010.11.013.
   PubMed Web of Science ®Google Scholar
• Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson. 2012;14(1):82. doi:10.1186/1532-429X-14-82.
   PubMed Web of Science ®Google Scholar
• Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: society for cardiovascular magnetic resonance (SCMR) board of Trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15(1):35. doi:10.1186/1532-429X-15-35.
   PubMed Web of Science ®Google Scholar
• Assomull RG, Shakespeare C, Kalra PR, et al. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation. 2011;124(12):1351–1360. doi:10.1161/CIRCULATIONAHA.110.011346.
   PubMed Web of Science ®Google Scholar
• Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New England J Med. 2000;343(20):1445–1453. doi:10.1056/NEJM200011163432003.
   PubMed Web of Science ®Google Scholar
• Hachulla A-L, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis. 2009;68(12):1878–1884. doi:10.1136/ard.2008.095836.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1304–1323. doi:10.1016/j.hrthm.2014.03.043.
   Web of Science ®Google Scholar
• Radunski UK, Lund GK, Stehning C, et al. CMR in patients with severe myocarditis. JACC: Cardiovascular Imaging. 2014;7(7):667–675. doi:10.1016/j.jcmg.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Lurz P, Luecke C, Eitel I, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis. J Am Coll Cardiol. 2016;67(15):1800–1811. doi:10.1016/j.jacc.2016.02.013.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Peker E, Chandrashekhar Y, et al. T1 mapping in characterizing myocardial disease. Circ Res. 2016;119(2):277–299. doi:10.1161/CIRCRESAHA.116.307974.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC: Cardiovascular Imaging. 2013;6(4):475–484. doi:10.1016/j.jcmg.2012.08.019.
   PubMed Web of Science ®Google Scholar
• Giri S, Chung Y-C, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009;11(1):56. doi:10.1186/1532-429X-11-56.
   PubMed Web of Science ®Google Scholar
• Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1(1):3–14.
   PubMedGoogle Scholar
• Escher F, Lassner D, Kuhl U, et al. Analysis of endomyocardial biopsies in suspected myocarditis—Diagnostic value of left versus right ventricular biopsy. Int J Cardiol. 2014;177(1):76–78. doi:10.1016/j.ijcard.2014.09.071.
   PubMed Web of Science ®Google Scholar
• Dec GW Jr., Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. New England J Med. 1985;312(14):885–890. doi:10.1056/NEJM198504043121404.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Foote L, Arroyo Ucar E, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis. JACC: Cardiovascular Imaging. 2015;8(1):37–46. doi:10.1016/j.jcmg.2014.07.016.
   PubMed Web of Science ®Google Scholar
• Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128(8):814–822. doi:10.1161/CIRCULATIONAHA.113.001719.
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American heart association, the American college of cardiology, and the European society of cardiology. Circulation. 2007;116(19):2216–2233. doi:10.1161/CIRCULATIONAHA.107.186093.
   PubMed Web of Science ®Google Scholar
• Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2007;29(2):270–276. doi:10.1093/eurheartj/ehm342.
   PubMed Web of Science ®Google Scholar
• Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapyclinical perspective. Circulation. 2011;124(17):1830–1837. doi:10.1161/CIRCULATIONAHA.111.026070.
   PubMed Web of Science ®Google Scholar
• Ferreira VM, Piechnik SK, Dall’Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14(1):42. doi:10.1186/1532-429X-14-42.
   PubMed Web of Science ®Google Scholar